Rapid improvements in health‐related quality of life and itch with ixekizumab treatment in randomized phase 3 trials: results from UNCOVER‐2 and UNCOVER‐3
C.L. Leonardi; A. Blauvelt; H.L. Sofen; M. Gooderham; M. Augustin; R. Burge; B. Zhu; K. Reich
Author Information: Central Dermatology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.